Search results
Results from the WOW.Com Content Network
A vaccine that contains the A/Vietnam/1194/2004 (H5N1) flu strain. [28] Pumarix: A vaccine approved for medical use in the European Union in March 2011. [29] Seqirus/Audenz: A vaccine for adults that contains a killed flu strain called A/Astrakhan/3212/2020 (H5N8)-like strain. [30] Some older H5N1 vaccines for humans that have been licensed are:
Treatments for influenza include a range of medications and therapies that are used in response to disease influenza. Treatments may either directly target the influenza virus itself; or instead they may just offer relief to symptoms of the disease, while the body's own immune system works to recover from infection.
The Centers for Disease Control and Prevention (CDC) identified the first two A/09(H1N1) swine flu cases in California on April 17, 2009, via the Border Infectious Disease Program, [135] for a San Diego County child, and a naval research facility studying a special diagnostic test, where influenza sample from the child from Imperial County was tested. [136]
(Reuters) -U.S. and California health officials confirmed two new cases of H5N1 bird flu in dairy farm workers in the state on Friday, bringing the total of infected dairy workers in that state to ...
A dozen more dairy herds in California have been stricken with bird flu as the virus continues to infect animals and humans around the U.S.. Nearly 700 herds in the state — or 71 percent of all ...
The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media due to the prevailing belief that it originated in pigs. The virus is believed to have originated around September 2008 in central Mexico.
As H5N1 bird flu spreads among California dairy herds and southward-migrating birds, health officials announced Friday that six more human cases of infection: five in California and one in Oregon ...
MedImmune said it was making a significant, rapid response with a vaccine to the novel H1N1 variant of influenza, known as swine flu. [10] In June 2009 it won a Department of Health and Human Services (HHS) contract, worth $90m.